WhaleCreep

Which hedge funds own ACRV? ACRIVON THERAPEUTICS INC, Q2 2026 13F holders

HealthcareBiotechnology

10 tracked hedge funds disclosed a position in ACRV (ACRIVON THERAPEUTICS INC) in their Q2 2026 13F filings, worth $25.8m in total. The largest holder by portfolio weight is RA Capital Management, L.P. at 0.2% of its book. 3 opened a new position this quarter: Spark Investment Management LLC, Verdad Advisers, LP, Citadel Advisors LLC.

10
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
3
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
0
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$151k
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$0
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$25.8m
Combined value
Sum of the holders' reported positions in the security.
0.8%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.

Holders, Q2 2026

10 rows
RA Capital Management, L.P. Hedge fund0.2%$21.8m12.23m+47%added
Spark Investment Management LLC Hedge fund0.10%$50.4k28,300–new
Verdad Advisers, LP Hedge fund0.03%$26.8k15,054–new
Gsa Capital Partners LLP Hedge fund0.02%$357k200,415+7.3%added
Prelude Capital Management, LLC Hedge fund0.0%$42.7k24,0150.0%held
Renaissance Technologies LLC Hedge fund0.0%$1.4m758,863+0.1%held
Two Sigma Investments, LP Hedge fund0.0%$1.1m641,498+65%added
Marshall Wace, LLP Hedge fund0.0%$947k531,856−5.1%reduced
Squarepoint Ops LLC Hedge fund0.0%$23.7k13,309−52%reduced
Citadel Advisors LLC Hedge fund0.0%$73.5k41,276–new